StockNews.com Begins Coverage on Mannatech (NASDAQ:MTEX)

StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a research report report published on Tuesday. The brokerage issued a buy rating on the stock.

Mannatech Stock Performance

MTEX opened at $8.20 on Tuesday. The company has a current ratio of 1.07, a quick ratio of 0.51 and a debt-to-equity ratio of 0.09. The business’s 50 day moving average is $8.67 and its 200-day moving average is $8.84. The stock has a market cap of $15.42 million, a PE ratio of -6.83 and a beta of 1.20. Mannatech has a twelve month low of $7.50 and a twelve month high of $15.93.

Institutional Trading of Mannatech

An institutional investor recently raised its position in Mannatech stock. Tower Research Capital LLC TRC lifted its stake in shares of Mannatech, Incorporated (NASDAQ:MTEX) by 167.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,575 shares of the company’s stock after purchasing an additional 987 shares during the quarter. Tower Research Capital LLC TRC owned about 0.08% of Mannatech worth $27,000 at the end of the most recent reporting period. Institutional investors own 12.98% of the company’s stock.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels.